Primary immune thrombocytopenia: novel insights into pathophysiology and disease management
A Singh, G Uzun, T Bakchoul - Journal of Clinical Medicine, 2021 - mdpi.com
Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …
Update on diagnosis and treatment of immune thrombocytopenia
Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …
The outcomes and adverse drug patterns of immunomodulators and thrombopoietin receptor agonists in primary immune thrombocytopenia Egyptian patients with …
Immune thrombocytopenia (ITP) treatment has evolved recently. However, none of the
treatments have only benefits without drawbacks. This study aimed to compare the clinical …
treatments have only benefits without drawbacks. This study aimed to compare the clinical …
Clinical care team's guide for awareness on risk assessment of eltrombopag complicating acute kidney injury in relapsed immune thrombocytopenic patients: a case …
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder caused by antigen-
specific T cells and antiplatelet autoantibodies that inhibit platelet production in the bone …
specific T cells and antiplatelet autoantibodies that inhibit platelet production in the bone …
[HTML][HTML] Safety and efficacy of azathioprine in immune thrombocytopenia
Background: Immune thrombocytopenia (ITP) is a benign hematological disorder
characterized by low platelet counts in peripheral blood and spectrum of various bleeding …
characterized by low platelet counts in peripheral blood and spectrum of various bleeding …
Therapeutic Outcomes of High Dose-Dexamethasone versus Prednisolone+ Azathioprine, Rituximab, Eltrombopag, and Romiplostim Strategies in Persistent, Chronic …
Background: Primary immune thrombocytopenia (ITP) is an inflammatory autoimmune
disease that can be managed with several treatment options. However, there is a lack of …
disease that can be managed with several treatment options. However, there is a lack of …
Bone marrow assessment in liver cirrhosis patients with otherwise unexplained peripheral blood cytopenia
SE Koschade, LM Moser, A Sokolovskiy… - Journal of Clinical …, 2023 - mdpi.com
We performed a retrospective single-center analysis to investigate the diagnostic yield of
bone marrow puncture in patients with liver cirrhosis and cytopenia. Liver cirrhosis patients …
bone marrow puncture in patients with liver cirrhosis and cytopenia. Liver cirrhosis patients …
[HTML][HTML] Safety and efficacy of splenectomy in immune thrombocytopenia
Background: Immune Thrombocytopenia (ITP) is characterized by low platelet counts.
Splenectomy has been in practice for the treatment of ITP since the early 20th century. We …
Splenectomy has been in practice for the treatment of ITP since the early 20th century. We …
Real-world experience of anti-D immunoglobulin in immune thrombocytopenia
In developing countries, anti-D has been used in immune thrombocytopenia (ITP) as a
cheaper alternative to human immunoglobulin. We aim to analyze the response and safety …
cheaper alternative to human immunoglobulin. We aim to analyze the response and safety …
How do patients and physicians perceive immune thrombocytopenia (ITP) as a disease? Results from Indian analysis of ITP World Impact Survey (I-WISh)
P Chakrabarti, B George, C Shanmukhaiah… - Journal of Patient …, 2022 - Springer
Purpose Immune thrombocytopenia (ITP) is primarily considered a bleeding disorder; its
impact on patients' health-related quality of life (HRQoL) is under-recognized. We aimed to …
impact on patients' health-related quality of life (HRQoL) is under-recognized. We aimed to …